AR016768A1 - COMPOSICIoN FARMACÉUTICA DE 5-(4- (2-(N-METIL-N-(2-PIRIDIL) AMINO)ETOXI)BENCIL)TIAZOLIDIN-2-4-DIONA Y UN SECRETAGOGO DE INSULINA Y USO DE LA MISMA PARA PREPARACIoN DE MEDICAMENTOS - Google Patents

COMPOSICIoN FARMACÉUTICA DE 5-(4- (2-(N-METIL-N-(2-PIRIDIL) AMINO)ETOXI)BENCIL)TIAZOLIDIN-2-4-DIONA Y UN SECRETAGOGO DE INSULINA Y USO DE LA MISMA PARA PREPARACIoN DE MEDICAMENTOS

Info

Publication number
AR016768A1
AR016768A1 ARP980103516A ARP980103516A AR016768A1 AR 016768 A1 AR016768 A1 AR 016768A1 AR P980103516 A ARP980103516 A AR P980103516A AR P980103516 A ARP980103516 A AR P980103516A AR 016768 A1 AR016768 A1 AR 016768A1
Authority
AR
Argentina
Prior art keywords
tiazolidin
piridil
etoxi
bencil
diona
Prior art date
Application number
ARP980103516A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10816177&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR016768(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR016768A1 publication Critical patent/AR016768A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP980103516A 1997-07-18 1998-07-17 COMPOSICIoN FARMACÉUTICA DE 5-(4- (2-(N-METIL-N-(2-PIRIDIL) AMINO)ETOXI)BENCIL)TIAZOLIDIN-2-4-DIONA Y UN SECRETAGOGO DE INSULINA Y USO DE LA MISMA PARA PREPARACIoN DE MEDICAMENTOS AR016768A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715306A GB9715306D0 (en) 1997-07-18 1997-07-18 Novel method of treatment

Publications (1)

Publication Number Publication Date
AR016768A1 true AR016768A1 (es) 2001-08-01

Family

ID=10816177

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980103516A AR016768A1 (es) 1997-07-18 1998-07-17 COMPOSICIoN FARMACÉUTICA DE 5-(4- (2-(N-METIL-N-(2-PIRIDIL) AMINO)ETOXI)BENCIL)TIAZOLIDIN-2-4-DIONA Y UN SECRETAGOGO DE INSULINA Y USO DE LA MISMA PARA PREPARACIoN DE MEDICAMENTOS
ARP990102953A AR019331A2 (es) 1997-07-18 1999-06-18 Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP990102953A AR019331A2 (es) 1997-07-18 1999-06-18 Composicion farmaceutica que contiene un sensibilizador a insulina y un secretagogo de insulina.

Country Status (40)

Country Link
EP (1) EP0998291B2 (en, 2012)
JP (2) JP2001510158A (en, 2012)
KR (1) KR100680667B1 (en, 2012)
CN (1) CN1264302A (en, 2012)
AP (1) AP1318A (en, 2012)
AR (2) AR016768A1 (en, 2012)
AT (1) ATE366577T1 (en, 2012)
AU (1) AU743269B2 (en, 2012)
BG (1) BG64892B1 (en, 2012)
BR (1) BR9810904A (en, 2012)
CA (1) CA2297115C (en, 2012)
CO (1) CO4940422A1 (en, 2012)
CY (1) CY1107745T1 (en, 2012)
CZ (1) CZ302668B6 (en, 2012)
DE (1) DE69838066T3 (en, 2012)
DK (1) DK0998291T4 (en, 2012)
DZ (1) DZ2564A1 (en, 2012)
EA (1) EA003303B1 (en, 2012)
ES (1) ES2290989T5 (en, 2012)
GB (1) GB9715306D0 (en, 2012)
HU (1) HU229119B1 (en, 2012)
ID (1) ID24198A (en, 2012)
IL (1) IL134045A0 (en, 2012)
IN (1) IN189035B (en, 2012)
MA (1) MA26522A1 (en, 2012)
MY (1) MY138246A (en, 2012)
NO (1) NO326356B1 (en, 2012)
NZ (3) NZ520652A (en, 2012)
OA (1) OA11632A (en, 2012)
PE (1) PE99799A1 (en, 2012)
PL (2) PL199125B1 (en, 2012)
PT (1) PT998291E (en, 2012)
SI (1) SI0998291T2 (en, 2012)
SK (2) SK287823B6 (en, 2012)
TR (1) TR200000135T2 (en, 2012)
TW (1) TW586926B (en, 2012)
UA (1) UA70302C2 (en, 2012)
UY (1) UY25103A1 (en, 2012)
WO (1) WO1999003476A1 (en, 2012)
ZA (1) ZA986365B (en, 2012)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
EP1832291A3 (en) * 1999-07-13 2009-11-04 Medicure Inc. use of pyridoxal phosphate for the treatment of diabetes and related complications
EP1897547A1 (en) * 1999-07-13 2008-03-12 Medicure Inc. Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
US6586438B2 (en) 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
EP1738751B1 (en) 2001-01-12 2011-05-11 Sun Pharma Advanced Research Company Ltd Spaced drug delivery system
NZ546337A (en) * 2003-10-31 2009-03-31 Takeda Pharmaceutical Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80
JP2008019169A (ja) * 2004-10-25 2008-01-31 Osaka Univ 新規ｐｐａｒ調節剤およびそのスクリーニング方法
AR058605A1 (es) 2005-12-22 2008-02-13 Takeda Pharmaceutical Preparacion solida

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group P.L.C., Brentford Substituierte Thiazolidindionderivate
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
WO1989008651A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Hypoglycemic thiazolidinedione derivatives
FI904414A0 (fi) * 1988-03-08 1990-09-07 Pfizer Tiazolidindion-hypoglykemiskt verkande aemnen.
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
ATE139130T1 (de) * 1991-08-16 1996-06-15 Sandoz Ag Inhalator zur verabreichung von pulverförmigen substanzen
WO1993003724A1 (en) * 1991-08-26 1993-03-04 The Upjohn Company Pharmaceutical composition containing 3-guanidinopropionic acid and pioglitazone glibenclamide or glimepiride
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes

Also Published As

Publication number Publication date
PT998291E (pt) 2007-10-11
DE69838066D1 (de) 2007-08-23
KR20010021948A (ko) 2001-03-15
KR100680667B1 (ko) 2007-02-09
HU229119B1 (en) 2013-08-28
NZ515555A (en) 2002-09-27
UY25103A1 (es) 2000-12-29
MY138246A (en) 2009-05-29
SK287823B6 (sk) 2011-11-04
SK288053B6 (sk) 2013-03-01
HUP0003634A2 (hu) 2001-07-30
HK1029272A1 (en) 2001-03-30
NO326356B1 (no) 2008-11-17
NZ520652A (en) 2004-06-25
EP0998291B2 (en) 2011-07-06
PE99799A1 (es) 1999-12-22
CZ2000173A3 (en) 2001-05-16
ATE366577T1 (de) 2007-08-15
BR9810904A (pt) 2000-09-26
NO20000229D0 (no) 2000-01-17
CO4940422A1 (es) 2000-07-24
SI0998291T1 (sl) 2007-12-31
SI0998291T2 (sl) 2011-10-28
SK602000A3 (en) 2000-07-11
ZA986365B (en) 2000-01-17
DE69838066T3 (de) 2012-03-29
DZ2564A1 (fr) 2003-02-15
CA2297115A1 (en) 1999-01-28
ES2290989T5 (es) 2011-11-11
HUP0003634A3 (en) 2003-04-28
NZ501256A (en) 2002-09-27
JP2005247865A (ja) 2005-09-15
CA2297115C (en) 2010-02-23
EA200000141A1 (ru) 2000-08-28
EP0998291B1 (en) 2007-07-11
AU8448798A (en) 1999-02-10
GB9715306D0 (en) 1997-09-24
ID24198A (id) 2000-07-13
PL199125B1 (pl) 2008-08-29
CN1264302A (zh) 2000-08-23
PL338127A1 (en) 2000-09-25
AP2000001734A0 (en) 2000-03-31
DE69838066T2 (de) 2008-03-20
EA003303B1 (ru) 2003-04-24
EP0998291A1 (en) 2000-05-10
CY1107745T1 (el) 2013-04-18
DK0998291T4 (da) 2011-09-26
BG104139A (en) 2000-11-30
TR200000135T2 (tr) 2000-05-22
AP1318A (en) 2004-10-22
JP2001510158A (ja) 2001-07-31
AU743269B2 (en) 2002-01-24
AR019331A2 (es) 2002-02-13
TW586926B (en) 2004-05-11
UA70302C2 (uk) 2004-10-15
DK0998291T3 (da) 2007-11-05
NO20000229L (no) 2000-01-17
IL134045A0 (en) 2001-04-30
WO1999003476A1 (en) 1999-01-28
IN189035B (en, 2012) 2002-12-07
ES2290989T3 (es) 2008-02-16
MA26522A1 (fr) 2004-12-20
OA11632A (en) 2004-11-22
CZ302668B6 (cs) 2011-08-24
BG64892B1 (bg) 2006-08-31

Similar Documents

Publication Publication Date Title
AR012995A1 (es) Uso de un sensibilizador a insulina y de un agente antihiperglucemico para la preparacion de medicamentos y composiciones farmaceuticas que contienedichos compuestos.
UY25799A1 (es) Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina y otro agente antidiabético.
CL2009001899A1 (es) Composicion farmaceutica que comprende: i) un antagonista del receptor de at1 o una sal, ii) un sensibilizante a la insulina o una sal y iii) un vehiculo farmaceuticamente aceptable; uso para la prevencion, demora de progreso o tratamiento de hipertension, diabetes, entre otras (div. sol. 2034-01).
AR025426A1 (es) Sales farmaceuticas de la sustancia activa tramadol y al menos un edulcorante, medicamentos que contienen estas sales, el uso de estas sales para lapreparacion de medicamentos y formas de administracion que contienen esas sales
BR9711098B1 (pt) compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
EA200200571A1 (ru) Новая композиция и ее применение
AR033688A1 (es) Composicion parenteral reconstituible
AR012997A1 (es) Uso de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4- diona e insulina para la preparacion de medicamentos, y composicionfarmaceutica que los contiene.
AR016768A1 (es) COMPOSICIoN FARMACÉUTICA DE 5-(4- (2-(N-METIL-N-(2-PIRIDIL) AMINO)ETOXI)BENCIL)TIAZOLIDIN-2-4-DIONA Y UN SECRETAGOGO DE INSULINA Y USO DE LA MISMA PARA PREPARACIoN DE MEDICAMENTOS
BR9810445A (pt) Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e diguanida
UY25798A1 (es) Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina tiazolidinadiónico.
NZ513922A (en) Composition comprising 5-Ä4-Ä2-(N-methyl-N-2-pyridyl)-amino)ethoxy!benzyl!thiazolidine-2-4-dione
AR012996A1 (es) Uso de un sensibilizador a la insulina para la preparacion de un medicamento y composicion farmaceutica que comprende dicho sensibilizador.
AR019724A2 (es) Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas
AR013352A1 (es) Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento para el tratamiento de la diabetes mellitus ycondiciones asociadas a la misma y una composicion farmaceutica.
ES2191908T3 (es) 4-aminopirrol(3,2-d)pirimidinas como antagonistas del receptor del neuropeptido.
AR002191A1 (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion
ES2166406T3 (es) Uso de derivados de 1,5-benzodiazepina para el control del vaciado gastrico en pacientes con diabetes mellitus no dependiente de insulina.
ECSP982593A (es) Nuevo metodo de tratamiento vi
CY1107767T1 (el) Παραγωγο θειαζολιδινοδιονης και χρηση αυτου σαν αντιδιαβητικο
ECSP982535A (es) Nuevo metodo de tratamiento (i)
PE20011042A1 (es) Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan
ECSP993215A (es) Nueva composicion y uso
CO5270004A1 (es) Composiciones farmaceuticas con agente del tipo biguanida para tratamientos en diabetes
TH50263A (th) การบำบัดรักษาด้วยวิธีใหม่

Legal Events

Date Code Title Description
FC Refusal